Search
Powered By HealthLine
Special Offers
TV Specials
 Learn about an Effective Alzheimer's Medication
 Bipolar Education Health Center
 Osteoarthritis of the Knee Solution Center
 Heartburn Education Center
 Breast Cancer Health Center
 Crohn's Disease Health Center
 Schizophrenia Education Center
Top Features
 Depression
 Schizophrenia
 Breast Cancer
 Bipolar
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
Drug Information
 Drug Search
 Drug Interactions
 Image Database
 Pill Identifier
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

New Drug Helps Smokers Quit and Stay Quit


Related Encyclopedia
 border=
Acne
Angina Pectoris
Angiogram
Angioplasty
More...

Related Healthscout Videos
 border=
Bubbles Predict Heart Attacks
Better CPR
Insulin For Heart Attacks
Breathing With Emphysema
More...

Related News Articles
 border=
Candy Cigarettes May Lead to the Real Thing
Smokers' Infants Have High Nicotine Levels
European Kids Using Banned Sports-Doping Drugs
Human Bites Usually Inflicted in Drunken Brawls
More...

Page:  << Prev | 1 | 2 | 3

The authors of the JAMA editorial -- which is subtitled Definite Promise, But No Panacea -- were reserved in their praise for the new drug.

"Several issues temper some of the enthusiasm for this agent," they wrote. One is the relatively high level of side effects noted in the trials, with almost 30 percent of participants reporting nausea, and many others experiencing "abnormal dreams" while on Chantix.

Drop-out rates were also high (35 percent in the Wisconsin trial), although this rate is similar to that usually seen in smoking-cessation trials. However, the editorialists pointed out that in the Norwegian trial, only those smokers who had quit by 12 weeks were allowed to enter the second, relapse-focused phase of the trial.

Text Continues Below



Because about one-third of the original participants did not succeed in quitting within three months, "the authors have eliminated [from their analysis] approximately one third of individuals for whom this drug does not appear to be effective," the Tennessee experts noted.

Finally, they said, all of these Pfizer-funded trials took place under the very best conditions, at academic research centers where smokers were closely monitored and instructed on proper use of the drugs.

That's a far cry from a "real world" situation where the average smoker is left more or less on his own after receiving a prescription from a doctor, they added.

So, while the results of these trials are promising, the editorialists pointed out that nicotine addiction remains an impossibly tough challenge for most smokers -- in fact, "the majority of participants in these three studies did not quit smoking, even with varenicline," they wrote.

The resilience of the smoking habit against all interventions suggests that "patients currently cannot and probably never will simply be able to 'take a pill' that will make them stop smoking," the editorialists concluded.

More information

For help on quitting smoking, head to Smokefree.gov (www.smokefree.gov ).

Page:  << Prev | 1 | 2 | 3

Copyright © 2006 ScoutNews, LLC. All rights reserved.
Last updated 7/4/2006

Related Links
 border=
From Healthscout's partner site on asthma, MyAsthmaCentral.com
VIDEO: Lung stents help asthmatics to breathe easier
TREATMENT: Medication and lifestyle changes provide asthma relief
DRUGS: Common drugs used to treat asthma





New Features

New ADHD Site!

SOURCES: Serena Tonstad, M.D., attending physician, department of preventive cardiology, Ulleval University Hospital, Oslo, Norway; July 5, 2006, Journal of the American Medical Association


We subscribe to the HONcode principles of the Health On the Net Foundation
About The HealthScout Network Contact Us
Copyright © 2001. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service   Site Map